Clinical Trials on Peanut Hypersensitivity in Chile
Total 90 results
-
Pontificia Universidad Catolica de ChileUniversity of Chile; Comisión Nacional de Investigación Científica y TecnológicaCompletedAsthma | Allergy | Atopic Dermatitis | Food Allergy | Allergic SensitisationChile
-
Pontificia Universidad Catolica de ChileCompletedParent-Child Relations | ParentingChile
-
Pontificia Universidad Catolica de ChileCompletedAtopic DermatitisChile
-
Universidad de ConcepcionUniversidad de Valparaiso; Comisión Nacional de Investigación Científica y... and other collaboratorsRecruitingAdherence, Medication | Primary Health Care | Asthma ChronicChile
-
University of ChileUnknownDentin SensitivityChile
-
Hospital do CoracaoBoehringer Ingelheim; Centro Rossi, Buenos Aires, ArgentinaRecruitingHypersensitivity PneumonitisArgentina, Brazil, Chile
-
SanofiCompletedAsthmaUnited States, Brazil, Poland, Russian Federation, Estonia, Mexico, Israel, Chile, Latvia, Puerto Rico, Costa Rica
-
AstraZenecaCompletedSevere AsthmaMexico, Argentina, Chile, Saudi Arabia, Colombia, Costa Rica
-
Circassia LimitedSyneos Health; CIDALCompleted
-
GlaxoSmithKlineCompletedAsthmaArgentina, Russian Federation, United States, Chile, Thailand
-
SanofiRecruitingAsthmaKorea, Republic of, Argentina, Chile, South Africa, United States, Hungary, Japan, Poland, Turkey, United Kingdom, Canada
-
SanofiRegeneron PharmaceuticalsActive, not recruitingAsthmaChile, Mexico, Singapore, Argentina, Colombia, Israel, Kuwait, Lebanon, Qatar, Russian Federation, Saudi Arabia, United Arab Emirates
-
AstraZenecaCompletedAsthmaCroatia, Czech Republic, Latvia, Lithuania, Portugal, Slovakia, Greece, Iceland, Slovenia, Chile
-
AstraZenecaCompletedAsthmaUnited States, Germany, Korea, Republic of, Philippines, Hungary, Chile
-
SanofiCompletedAsthmaSpain, Korea, Republic of, Chile, Mexico, United Kingdom, Argentina, Bulgaria, Canada, Hungary, Poland, Romania, Turkey, Germany
-
SanofiRegeneron PharmaceuticalsCompletedAsthmaUkraine, United States, Argentina, Chile, Mexico, Poland, Russian Federation, Turkey
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Russian Federation, Mexico, France, Chile
-
GlaxoSmithKlineCompletedAsthmaGermany, Romania, Bulgaria, Chile, Russian Federation, South Africa, Estonia, Italy, Mexico, Greece, Hungary, Croatia, Brazil
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Chile, Germany, Hungary, Italy, Korea, Republic of, Latvia, Mexico, Russian Federation, Slovakia, Spain, Ukraine
-
SkyePharma AGAbbott; MDS Pharma ServicesCompletedAsthmaUnited States, Chile, Mexico, Peru, Romania, Hungary, South Africa, Ukraine, Poland, Argentina
-
SanofiRegeneron PharmaceuticalsCompletedAsthmaBelgium, Israel, United States, Mexico, Argentina, Brazil, Canada, Chile, Colombia, Hungary, Italy, Netherlands, Poland, Romania, Russian Federation, Spain, Ukraine
-
Northwestern UniversityCompletedPsoriasis | Atopic DermatitisChile, United States, Netherlands, Canada, Hong Kong, Italy
-
GlaxoSmithKlineCompletedAsthmaUnited States, Russian Federation, Canada, Germany, Peru, Australia, Mexico, Chile, Costa Rica, Spain, Poland, Lithuania, Latvia
-
SanofiRegeneron PharmaceuticalsCompletedAsthmaSpain, Mexico, United States, Hungary, Italy, Argentina, Australia, Brazil, Canada, Chile, Colombia, Lithuania, Poland, Romania, Russian Federation, South Africa, Turkey, Ukraine
-
SanofiRecruitingAsthmaChina, Turkey, Argentina, India, Israel, Korea, Republic of, Brazil, United States, Chile, Japan
-
GlaxoSmithKlineCompletedAsthmaUnited States, Australia, Germany, Russian Federation, Bulgaria, Canada, Chile, Peru, Philippines, South Africa, Thailand, Mexico, Israel, Ukraine, New Zealand, Croatia
-
GlaxoSmithKlineCompletedHZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and AdolescentsAsthmaUnited States, Argentina, Korea, Republic of, Netherlands, Philippines, Chile
-
Novartis PharmaceuticalsCompletedChronic Spontaneous UrticariaArgentina, Dominican Republic, Canada, Brazil, Guatemala, Chile, Mexico, Panama
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Poland, Russian Federation, Belgium, Canada, Chile, France, Germany, Korea, Republic of, Netherlands, Peru, Philippines, South Africa, Sweden, Thailand
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Australia, Germany, Poland, Romania, Russian Federation, Ukraine, Canada, Chile, France, Korea, Republic of, United Kingdom
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Australia, France, Germany, Poland, Romania, Russian Federation, Canada, Chile, Korea, Republic of, Ukraine, United Kingdom
-
GlaxoSmithKlineRecruitingAsthmaUnited States, Australia, Argentina, Korea, Republic of, Mexico, Turkey, Chile
-
SanofiRegeneron PharmaceuticalsActive, not recruitingAsthmaMexico, Spain, Argentina, Japan, Poland, United States, Turkey, Australia, Brazil, Canada, Chile, Colombia, Hungary, Italy, Lithuania, Russian Federation, South Africa, Ukraine
-
MedImmune LLCCompletedAsthmaUnited States, Czech Republic, France, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, United Kingdom, Germany, Philippines, Argentina, Canada, Chile, Japan
-
SanofiCompletedAtopic DermatitisNetherlands, Chile, United States, Canada, Czechia, Germany, Poland
-
AstraZenecaAmgenRecruitingAsthmaUnited States, Canada, Czechia, Korea, Republic of, India, Mexico, Turkey, Chile, Brazil, Thailand, Colombia, Poland, Peru, Malaysia, Philippines
-
AstraZenecaRecruitingAsthmaUnited States, Argentina, Italy, Mexico, Germany, Hungary, Netherlands, Poland, Spain, Korea, Republic of, Bulgaria, Ukraine, Serbia, Turkey, Slovakia, United Kingdom, Chile, Australia, Croatia, Japan, Romania, South Africa, France, S...
-
AstraZenecaCompletedAsthmaUnited States, Canada, France, Turkey, Korea, Republic of, Argentina, Germany, Poland, Ukraine, Spain, Bulgaria, Chile
-
GlaxoSmithKlineCompleted
-
Novartis PharmaceuticalsTerminatedAsthmaGermany, Belgium, South Africa, United States, Russian Federation, France, Slovakia, Spain, Thailand, Czechia, Greece, Argentina, Peru, United Kingdom, Bulgaria, Turkey, Hungary, Vietnam, Philippines, Colombia, Chile
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Australia, Canada, France, Germany, Japan, Russian Federation, Spain, Ukraine, Belgium, Chile, Korea, Republic of, Mexico, Italy, United Kingdom
-
GlaxoSmithKlineCompletedRhinitis, Allergic, PerennialUnited States, Argentina, Slovakia, Finland, Chile, Mexico, Italy
-
SanofiActive, not recruitingDose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma (TIDE-asthma)AsthmaUnited States, Argentina, Brazil, Canada, Chile, Hungary, Italy, Japan, Korea, Republic of, Mexico, Poland, South Africa, Turkey, United Kingdom
-
Novartis PharmaceuticalsCompletedAsthmaGermany, India, Israel, Poland, Argentina, Russian Federation, Greece, Serbia, Turkey, Hungary, Mexico, Peru, Slovakia, Czechia, South Africa, Taiwan, Vietnam, Spain, Colombia, Chile
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Germany, Romania, Russian Federation, Ukraine, Chile, Sweden, Mexico, Netherlands, Poland
-
Novartis PharmaceuticalsCompletedMild AsthmaGermany, India, Korea, Republic of, Poland, South Africa, Estonia, Italy, Russian Federation, Thailand, Latvia, Lithuania, Colombia, Hungary, Peru, Philippines, Slovakia, Bulgaria, Vietnam, Japan, Malaysia, Chile, Sweden
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Australia, Canada, France, Germany, Japan, Netherlands, Poland, Russian Federation, Spain, Ukraine, Belgium, Chile, Korea, Republic of, United Kingdom, Czechia, Mexico, Italy
-
AstraZenecaCompletedAsthmaCanada, Vietnam, Russian Federation, Korea, Republic of, Brazil, Peru, China, Ukraine, South Africa, Australia, Bulgaria, Hungary, Poland, Philippines, Romania, Mexico, Chile, United Kingdom
-
SanofiRecruitingDermatitis AtopicJapan, Chile, Canada, Argentina, Brazil, France, United States, Turkey, China
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Germany, Japan, Chile, Peru, Philippines, Poland, Mexico, Slovakia, Ukraine, South Africa, Puerto Rico, Georgia